A PVC-based sensor for La(3+) ions based on N-[hexahydrocyclopentapyrol-2((1H)yl)amino]carbonyl]-4-methyl benzene sulfonamide (gliclazide) as a novel carrier was prepared. The electrode exhibits a Nernstian response for La(3+) over a wide concentration range (1.0x10(-1)-1.0x10(-6) M) with a slope of 20.1 mV per decade. The limit of detection is 8.0x10(-7) M. The sensor has a very short response time (<15 s) and a useful working pH range of 4.0-8.0. The proposed membrane sensor shows excellent discriminating ability towards La(3+) ions with regard to several alkali, alkaline earth, transition and heavy metal ions. The electrode was successfully applied for determination of La(3+) in binary mixtures.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/s0039-9140(02)00573-8 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Leveraging Green Chromatography in Quality-by-Design-Driven Study for the Simultaneous Analysis of Essential Single-Pill Antidiabetic Drug Combinations.
J Sep Sci
December 2024
Natural and Medical Sciences Research Center, University of Nizwa, Nizwa City, Oman.
Micellar liquid chromatography (MLC) has proven beneficial efficiency and ecological impact for routine quality control activities. In the proposed study, cyrene was investigated for the first time, together with other green additives, as a novel safe organic solvent in reversed-phase MLC. Quality-by-design (QbD) approach screened their effect on the separation performance.
View Article and Find Full Text PDFA novel heterozygous likely pathogenic SLC5A2 variant in a diabetic patient with glucosuria and aminoaciduria.
Endocrinol Diabetes Metab Case Rep
July 2024
Department of Endocrinology, CHU Brugmann, Université Libre de Bruxelles, Brussels, Belgium.
Summary: Familial renal glucosuria (FRG) is a rare renal tubular disorder characterized by increased urinary glucose excretion despite normoglycemia. It is most commonly caused by pathogenic variants in the solute carrier family V member 2 (SLC5A2) gene. This gene encodes the sodium-glucose cotransporter 2, crucial for glucose reabsorption.
View Article and Find Full Text PDFHepatoprotective potential of alpha-lipoic acid against gliclazide-induced liver injury in high-glucose-exposed human liver cells and experimental type 2 diabetic rats.
Biochem Pharmacol
September 2024
Department of Medical Pharmacology, University of Ghana Medical School, Korle-Bu, Accra, Ghana.
Growing clinical evidence shows that sulfonylurea therapy for patients with type 2 diabetic mellitus (T2DM) contributes to progressive worsening of their liver. The present study presents hepatotoxicity induced by gliclazide, a second-generation sulfonylurea, and alpha-lipoic acid (ALA) as a novel and promising drug for T2DM treatment. Normal human liver cells (HL-7702) were incubated with high-glucose DMEM in the presence or absence of gliclazide and ALA for 72 h, and cell viability and death were measured by flow cytometry.
View Article and Find Full Text PDFPharmacological inhibition of PDGF-C/neuropilin-1 interaction: A novel strategy to reduce melanoma metastatic potential.
Biomed Pharmacother
July 2024
Laboratory of Molecular Oncology, IDI-IRCCS, Rome, Italy. Electronic address:
Article Synopsis
- Activation of neuropilin-1 (NRP-1) by PDGF-C promotes melanoma invasiveness, leading researchers to explore this interaction as a target for new treatments to reduce melanoma spread.
- By analyzing the structural similarities between PDGF-C and VEGF-A, scientists hypothesized that a specific region on NRP-1 involved in VEGF-A binding might also interact with PDGF-C.
- After screening compounds from DrugBank, two existing medications, gliclazide and entrectinib, were identified as effective in disrupting the PDGF-C/NRP-1 interaction, thereby inhibiting melanoma cell migration and invasion at non-toxic levels.
Polydimethylsiloxane Organic-Inorganic Composite Drug Reservoir with Gliclazide.
Int J Mol Sci
April 2024
Curtin Medical School, Curtin University, Bentley 6102, Australia.
A novel organic-inorganic gliclazide-loaded composite bead was developed by an ionic gelation process using acidified CaCl, chitosan and tetraethylorthosilicate (TEOS) as a crosslinker. The beads were manufactured by crosslinking an inorganic silicone elastomer (-OH terminated polydimethylsiloxane, PDMS) with TEOS at different ratios before grafting onto an organic backbone (Na-alginate) using a 3 factorial experimental design. Gliclazide's encapsulation efficiency (EE%) and drug release over 8 h (% DR 8 h) were set as dependent responses for the optimisation of a pharmaceutical formula (herein referred to as 'G op') by response surface methodology.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!